Gene-Edited Stem Cells for Disease and Drug Discovery

CRISPR gene-editing technology revolutionized disease research and drug discovery by facilitating convenient gene modification and high-throughput screening. Researchers now combine the power of CRISPR technology with the biological versatility of stem cells to develop better therapeutic models, uncover disease pathology, and identify viable pharmaceutical targets. This webinar will discuss recent disease and drug discoveries enabled through screening CRISPR-modified stem cells.

Topics to be covered

CRISPR-Cas9 screening for drug target discovery
Using CRISPR-based transient reporters for editing enrichment to generate human pluripotent stem cell-based models of Alzheimer's disease

Speaker Information:

Graham MacLeod, PhD

Senior Research Associate

Laboratory of Stephane Angers, PhD

Department of Pharmaceutical Sciences

University of Toronto

David circle

David Brafman, PhD, MBA

Associate Professor, School of Biological and Health Systems Engineering

Director, Stem Cell Training and Research Program

Arizona State University

Webinar Sponsor